Adenocarcinoma of the small bowel at a single Korean institute: management and prognosticators
- PMID: 19760196
- PMCID: PMC11828314
- DOI: 10.1007/s00432-009-0668-3
Adenocarcinoma of the small bowel at a single Korean institute: management and prognosticators
Abstract
Purpose: Small bowel adenocarcinoma (SBA) is a rare malignancy with a poor outcome. We evaluated the natural history of SBA at a single Korean institute.
Methods: Medical records of 100 patients with SBA were reviewed for clinical characteristics, treatment patterns, outcomes, and prognostic factors.
Results: The most common primary tumor site was the duodenum (82%). Seventy-four patients were diagnosed with stage III/IV disease (28/46 patients, respectively). Sixty-six patients had surgery (R0/R1/R2 in 32/2/32) without operation-related mortality. Of 34 R0/R1-resected patients, 16 received adjuvant chemotherapy. The dominant pattern of recurrence following R0/R1 resection was distant metastasis (29%; 10 of 34 patients). Thirty-four patients with advanced SBA received palliative chemotherapy, showing a response rate of 27.6% and a median progression-free survival of 3.8 months. The median overall survival for all patients and R0/R1-resected patients was 10.5 and 42.1 months, respectively. In multivariate analysis, lower stage, nonduodenal location, and R0/R1 resection were good independent prognostic factors.
Conclusions: Early diagnosis is crucial to improve outcomes of SBA with respect to increasing resectability. Distant metastasis as a dominant pattern of recurrence suggests a potential role for adjuvant chemotherapy. Newer antitumor agents in advanced SBA should be evaluated considering the poor efficacy of current palliative chemotherapy.
Figures
References
-
- Agrawal S, McCarron EC, Gibbs JF, Nava HR, Wilding GE, Rajput A (2007) Surgical management and outcome in primary adenocarcinoma of the small bowel. Ann Surg Oncol 14:2263–2269 - PubMed
-
- Aparicio T, Costes L, Moulin V, Locher C, Bidault A, Lecomte T, Mitry E, Taieb J, Landi B, Malka D (2007) Efficacy of recent chemotherapy regimen in advanced small bowel carcinoma. J Clin Oncol 25(18 Suppl): (Abstract 15112)
-
- Barnes G, Romero L, Hess KR, Curley SA (1994) Primary adenocarcinoma of the duodenum: management and survival in 67 patients. Ann Surg Oncol 1:73–78 - PubMed
-
- Bauer RL, Palmer ML, Bauer AM, Nava HR, Douglass HO (1994) Adenocarcinoma of the small intestine: 21-year review of diagnosis, treatment, and prognosis. Ann Surg Oncol 1:183–188 - PubMed
-
- Bilimoria KY, Bentrem DJ, Wayne JD, Ko CY, Bennett CL, Talamonti MS (2009) Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg 249:63–71 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
